Description
DIVES AMI 200 is a professional injectable skin booster developed by DIVES Med, formulated as an amino acid–based solution intended to support skin revitalisation and dermal conditioning. The product belongs to the category of biorevitalising injectables and is designed to be administered intradermally by qualified medical professionals under controlled clinical conditions.
DIVES AMI 200 contains a complex of amino acids that are physiologically involved in dermal metabolic processes, including structural protein support and cellular function. Rather than providing volumisation or contour correction, the product is positioned to support overall skin quality, hydration balance, and tissue vitality through biochemical support mechanisms.
DIVES AMI 200 is not classified as a dermal filler and does not contain cross-linked hyaluronic acid for structural augmentation. Its clinical use is aligned with protocols focused on skin revitalisation, particularly in patients presenting with early signs of skin fatigue, reduced elasticity, or dull appearance. The product is supplied as a sterile injectable solution for professional aesthetic use only.
What DIVES AMI 200 Is Similar To
DIVES AMI 200 is most comparable to other amino acid–based injectable skin boosters used for biorevitalisation rather than volumisation. Products such as Sunekos® are often referenced for orientation, as they also utilise amino acids to support dermal function and skin quality.
While Sunekos® combines amino acids with hyaluronic acid, DIVES AMI 200 is positioned primarily as an amino acid solution without a stated HA concentration in publicly available documentation. Both products are used in protocols aimed at improving skin condition, elasticity, and hydration rather than providing structural volume.
In contrast, injectable products such as Profhilo® rely on stabilised hyaluronic acid complexes and act through different biological and physical mechanisms. Treatment response and longevity may vary depending on patient factors, skin condition, and practitioner-defined protocols.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to publicly available manufacturer and distributor information, DIVES AMI 200 is indicated for injectable skin revitalisation.
Specific anatomical treatment areas are not provided by the manufacturer in accessible IFU-level documentation .
Usage / Administration (IFU-only section)
The following administration parameters are based strictly on publicly available manufacturer information:
-
Injection depth: not provided by manufacturer
-
Volume per point / injection site: not provided by manufacturer
-
Needle gauge: not provided by manufacturer
-
Frequency / number of sessions: not provided by manufacturer
Professional-use disclaimer: DIVES AMI 200 is intended for administration only by qualified medical professionals under aseptic clinical conditions [1].
⚠️ Some practitioners apply specific mesotherapy techniques in clinical practice; however, these methods are not included in the manufacturer’s official IFU and are therefore not described here.
Ingredient List
Based on publicly available information:
-
Amino acid complex (specific composition and concentrations not disclosed by manufacturer)
Hyaluronic acid concentration: not provided by manufacturer
Contains lidocaine: not provided by manufacturer
Presentation & Longevity
-
Presentation: 1 × 5 ml sterile injectable vial or syringe (as listed by distributors)
-
Treatment longevity: not provided by manufacturer
Clinical outcomes and duration of effect may vary depending on individual patient factors and treatment protocol.
Safety Notes / Contraindications
Public IFU documentation does not provide a comprehensive contraindication list. Standard safety considerations for injectable skin boosters apply:
-
Contraindicated in patients with known hypersensitivity to any component of the product
-
Do not use in areas with active infection, inflammation, or compromised skin integrity
-
For professional use only; administration must be performed by qualified medical practitioners under aseptic conditions
Regulatory Status
DIVES AMI 200 is marketed in the EU and UK as a medical-aesthetic injectable device.
CE marking is referenced by multiple authorised distributors.
UKCA status: regulatory classification not specified in public documentation; verify on the product pack or manufacturer’s IFU.
FAQ
Q1: What type of injectable is DIVES AMI 200?
DIVES AMI 200 is classified as an injectable skin booster or biorevitaliser. It is formulated with amino acids and is designed to support skin quality and dermal conditioning rather than volume restoration or contour correction .
Q2: Does DIVES AMI 200 act as a dermal filler?
No. DIVES AMI 200 is not a dermal filler and does not contain cross-linked hyaluronic acid intended for structural augmentation. It should not be used for wrinkle filling or facial contouring .
Q3: How is DIVES AMI 200 administered?
The manufacturer does not publicly specify injection depth, volume per point, needle gauge, or treatment frequency. The product is intended for professional use only, and clinicians must follow the official IFU supplied with the packaging .
Q4: How long do the effects of DIVES AMI 200 last?
The manufacturer does not state an expected duration of effect. As with other biorevitalising injectables, outcomes may vary depending on patient characteristics, skin condition, and practitioner-defined protocol .
Q5: How does DIVES AMI 200 compare to HA-based skin boosters?
Unlike HA-based boosters such as Profhilo®, DIVES AMI 200 relies on an amino acid–based formulation. Both aim to improve skin quality, but they differ in composition, mechanism of action, and manufacturer-defined indications .
